Madam Speaker, the member in his speech talked about an offer we cannot refuse. The last time I heard that line, things did not go so well in that particular situation.
All kidding aside, I would like to ask my colleague a question about the cost of prescription drugs. That issue is often forgotten in this debate. We have been talking a lot about the investor-state dispute settlement clauses and the impact on the dairy industry, particularly in my province of Quebec, and with good reason. However, the cost of medication is going to increase by approximately $850 million, which will affect not only the provinces, which administer the health care system, but also the people who have to pay for those medications.
Although we recognize the importance of free trade with Europe, I would like to know what my colleague thinks about the impact this will actually have on the cost of living of people who need medication, particularly seniors.